The Future of Cell Therapy
Stimulating the immune system to protect the host from infectious diseases has been a triumphal area of research since the 18th century. As of then, scientists believed in extending this success to generate protective and/or therapeutic cancer vaccines. Unfortunately however, all attempts using the standard dentritic cell approach failed for various technical and manufacturing reasons.
With its deep knowledge in antigen processing and presentation, IntelliStem has developed revolutionizing stem cell medicine based on its proprietary technology: genetically engineered Super Sentinel Cells™ (SSC’s). With their ability to smartly educate T cells, Super Sentinel Cells™ direct the immune system towards cancer cells and other intruders to the body with an unprecedented 80% success rate.
